Cargando…

The Use of Antiallergic and Antiasthmatic Drugs in Viral Infections of the Upper Respiratory Tract

Despite their frequency, upper respiratory tract infections (URTIs) constitute an area with few, if any, effective treatment remedies. Asthma and airway allergies share similar pathogenetic mechanisms to URTIs and it is not surprising, therefore, that agents used to treat allergic disorders have als...

Descripción completa

Detalles Bibliográficos
Autor principal:	Åberg, Nils
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2012
Materias:	Leading Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100695/ https://www.ncbi.nlm.nih.gov/pubmed/32226274 http://dx.doi.org/10.1007/BF03259516

Ejemplares similares

Exercise and Upper Respiratory Tract Infections: Is There a Relationship?
por: Heath, Gregory W., et al.
Publicado: (2012)

Effect of Selected Antiasthmatic Plant Constituents Against Micro Organism Causing Upper Respiratory Tract Infection
por: Nilani, P., et al.
Publicado: (2010)

Cariogenic Potential of Inhaled Antiasthmatic Drugs
por: Brigic, Amela, et al.
Publicado: (2015)

Viral Upper Respiratory Tract Infections
por: Guibas, George V., et al.
Publicado: (2017)

Role of Viral Infection in the Aetiology of Multiple Sclerosis: Status of Current Knowledge and Therapeutic Implications
por: Berti, Rossana, et al.
Publicado: (2012)

A review on herbal antiasthmatics
por: Mali, Ravindra G., et al.
Publicado: (2011)

Severe Acute Respiratory Syndrome and Sport: Facts and Fallacies
por: So, Raymond C. H., et al.
Publicado: (2012)

Severe Acute Respiratory Syndrome: Pertinent Clinical Characteristics and Therapy
por: File, Thomas M., et al.
Publicado: (2012)

Drugs in Development for Malaria
por: Ashley, Elizabeth A., et al.
Publicado: (2018)

Perispinal Delivery of CNS Drugs
por: Tobinick, Edward Lewis
Publicado: (2016)

Drugs in Development for Hepatitis B
por: Dawood, Altaf, et al.
Publicado: (2017)

Nutritional status and eating habits of people who use drugs and/or are undergoing treatment for recovery: a narrative review
por: Mahboub, Nadine, et al.
Publicado: (2020)

Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs
por: Luginina, Aleksandra, et al.
Publicado: (2019)

Trends in the use of antiasthmatic medications in Morocco (1999–2010)
por: Ghanname, Imane, et al.
Publicado: (2013)

Recent Advances in Antiarrhythmic Drug Therapy
por: Saljic, Arnela, et al.
Publicado: (2023)

Therapeutic and Prophylactic Potential of Small Interfering RNAs against Severe Acute Respiratory Syndrome: Progress to Date
por: Chang, Zhijie, et al.
Publicado: (2012)

Impact on Drug Safety of Variation in Adherence: The Need for Routinely Reporting Measures of Dose Intensity in Medication Safety Studies Using Electronic Health Data
por: Roughead, Elizabeth E., et al.
Publicado: (2015)

MicroRNA: Potential Targets for the Development of Novel Drugs?
por: Wu, Wei
Publicado: (2012)

Synthesis, antiasthmatic, and insecticidal/antifungal activities of allosamidins
por: Huang, Gangliang, et al.
Publicado: (2019)

The New Era of Drug Therapy for Obesity: The Evidence and the Expectations
por: Jones, Ben J., et al.
Publicado: (2015)

Novel Pulmonary Delivery of Drugs for the Management of Atrial Fibrillation
por: Islam, Nazrul, et al.
Publicado: (2022)

Viral and Bacterial Interactions in the Upper Respiratory Tract
por: Bosch, Astrid A. T. M., et al.
Publicado: (2013)

Auranofin: Repurposing an Old Drug for a Golden New Age
por: Roder, Christine, et al.
Publicado: (2015)

Incorporating Pharmacometrics into Pharmacoeconomic Models: Applications from Drug Development
por: Srinivasan, Meenakshi, et al.
Publicado: (2020)

The Challenging Pharmacokinetics of Mitotane: An Old Drug in Need of New Packaging
por: Haider, Malik Salman, et al.
Publicado: (2021)

Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent Pain
por: Sisignano, Marco, et al.
Publicado: (2022)

Drug Treatment of Hypercholesterolemia in Older Adults: Focus on Newer Agents
por: Stoll, Felicitas, et al.
Publicado: (2022)

Targeted Small Molecules for Systemic Lupus Erythematosus: Drugs in the Pipeline
por: Mok, Chi Chiu
Publicado: (2023)

Frequency of viral etiology in symptomatic adult upper respiratory tract infections
por: da Silva, Raquel Cirlene, et al.
Publicado: (2014)

Overview of Current Drugs and Molecules in Development for Spinal Muscular Atrophy Therapy
por: Shorrock, Hannah K., et al.
Publicado: (2018)

The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance
por: Tuccori, Marco, et al.
Publicado: (2020)

Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease
por: Di Luca, Daniel Garbin, et al.
Publicado: (2022)

Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?
por: Alamri, Ayedh K., et al.
Publicado: (2023)

Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
por: Michaeli, Daniel Tobias, et al.
Publicado: (2023)

Ongoing Developments and Clinical Progress in Drug-Loaded Red Blood Cell Technologies
por: Rossi, Luigia, et al.
Publicado: (2020)

Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials
por: Hey-Hadavi, Juliana, et al.
Publicado: (2021)

Antiallergic Phorbol Ester from the Seeds of Aquilaria malaccensis
por: Korinek, Michal, et al.
Publicado: (2016)

Evaluation of Drug Prescribing Habits in a Postgraduate Teaching Set-up in Saudi Arabia
por: AI-Dawood, Kasim
Publicado: (1995)

How the Global COVID-19 Pandemic Brought Drug and Vaccine Development into the Public Mainstream
por: Witek, Theodore J.
Publicado: (2021)

UPPER RESPIRATORY TRACT INFECTION
por: Heikkinen, T., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_nd18qp7bum83jm5mqtn8s7um3b